SPOTLIGHT -
Xcovery set to begin Phase I/II AMD trial with oral drug candidate
Xcovery Holdings starts Phase I/II trials of oral angiogenesis inhibitor, X-82, for neovascular wet age-related macular degeneration (AMD).
PBA Supports National Falls Prevention Awareness Day
People with vision impairments are more than twice as likely to fall. So Prevent Blindness America (PBA) supports National Falls Prevention Day on the 22nd.